Restylane Refyne, Restylane Defyne, Restylane Kysse Injectable Gels
FDA premarket approval P140029/S035 · decided 2021-06-11
Approval details
- PMA number
- P140029
- Supplement
- S035
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Restylane Refyne, Restylane Defyne, Restylane Kysse Injectable Gels
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2021-01-21
- Decision date
- 2021-06-11
- Days to decision
- 141 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Approval for installation of new equipment and modification of a control panel in clean rooms at Uppsala, Sweden
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.